Skip to content

Ultrasound-guided Thyroid Cartilage Plane Block for Awake Intubation

Ultrasound-guided Thyroid Cartilage Plane Block for Patients With Awake Tracheal Intubation: a Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06065475
Enrollment
60
Registered
2023-10-04
Start date
2023-10-15
Completion date
2024-12-28
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior Laryngeal Nerve Block

Keywords

Thyroid Cartilage, Superior Laryngeal Nerve, Difficult airway, ultrasound, Awake tracheal intubation

Brief summary

The goal of this clinical trial is to investigate the clinical effectiveness and safety of superior laryngeal nerve block through surface injection of local anesthetic solution on the thyroid cartilage in patients undergoing general anesthesia with endotracheal intubation. The main questions it aims to answer are the effectiveness of ultrasound-guided Thyroid Cartilage Plane Block for superior laryngeal nerve blockadethe and the safety and ease of performance. All patients are divided into the Thyroid Cartilage Plane Block Group (T Group) and the Control Group (C Group). Patients in the C Group receive airway surface anesthesia using the fiberoptic bronchoscope-guided local anesthetic spray method throughout the procedure. In the experimental T Group, ultrasound-guided bilateral Thyroid Cartilage Plane Block is performed using the thyroid cartilage as an anatomical landmark. Local anesthetic is injected on the surface of the thyroid cartilage. Compare the following parameters between the two groups: duration of the blocking procedure, Ramsay Sedation Score, patient coughing upon contact of the fiberoptic bronchoscope with the vocal cords before intubation, comfort score immediately after intubation, and tracheal tube tolerance after successful intubation.

Detailed description

Select 60 patients undergoing elective awake tracheal intubation surgery. Instruct patients to fast (no food or drink) for 8 hours before the procedure. Upon admission to the operating room, monitor patients' ECG (electrocardiogram), BP (blood pressure), and SpO2 (pulse oxygen saturation). Establish intravenous access in the upper extremities and administer normal saline solution. Administer a loading dose of dexmedetomidine at 0.5 μg/kg over 5 minutes and remifentanil 0.5μg.kg-1, followed by an infusion at a rate of 0.3-0.6 μg/(kg·h) , 0.1μg.kg-1.min-1 by micropump infusion respectively. Perform radial artery puncture and catheter placement for invasive arterial pressure monitoring. Use a computer-generated random number table to allocate patients into two groups in a 1:1 ratio. To ensure objectivity, a nurse not involved in the study prepares sealed opaque envelopes containing the group assignments. All patients are divided into the Thyroid Cartilage Plane Block Group (T Group) and the Control Group (C Group). All patients received topical oral and pharyngeal anesthesia using 2.4% lidocaine spray administered by an experienced anesthesiologist. The pharyngeal surface was sprayed twice, with each spray lasting one second, and repeated after a 5-minute interval. Each spray contained approximately 16 mg lidocaine. Patients in the C Group receive airway surface anesthesia using the fiberoptic bronchoscope-guided local anesthetic spray method throughout the vocal cord and tracheal with 5 ml 2% lidocaine respectively. In the experimental T Group, ultrasound-guided bilateral Thyroid Cartilage Plane Block is performed using the thyroid cartilage plate as an anatomical landmark.2.5 ml 2% lidocaine local anesthetic is injected on the surface of the thyroid cartilage plate. The blocking procedure is as follows: Use a Sonosite high-frequency linear array transducer (5-13 MHz, Sonosite, USA). Place the transducer parallel to the spine on one side of the neck, ensuring clear visualization of the thyroid cartilage plate under ultrasound. Employ ultrasound-guided out-of-plane techniques to display the needle insertion path and tip. Once the needle tip contacts the upper half of the thyroid cartilage plate, inject 2.5ml of 2% lidocaine on the surface of the thyroid cartilage plate (the dosage is consistent with the commonly used local anesthetic volume for classic superior laryngeal nerve block methods in clinical practice). Subsequently, perform fiberoptic bronchoscope-guided subglottic, and tracheal surface anesthesia. After completing surface anesthesia, select an appropriate-sized tracheal tube and perform fiberoptic bronchoscope-guided tracheal intubation, securing it properly.

Interventions

Use a SonoSite high-frequency linear array transducer (5-13 MHz, SonoSite, USA). Place the transducer parallel to the spine on one side of the neck, ensuring clear visualization of the thyroid cartilage plate under ultrasound. Employ ultrasound-guided out-of-plane techniques to display the needle insertion path and tip. Once the needle tip contacts the upper half of the thyroid cartilage plate, injecting 2.5ml of 2% lidocaine on the surface of the thyroid cartilage each side.

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Patients scheduled for awake tracheal intubation surgery under general anesthesia. 2. Patients with difficult airways (e.g., limited cervical spine mobility, full stomach, partial airway obstruction, craniofacial deformities or trauma, micrognathia, mouth opening \<3cm, Mallampati III or IV classification) posing challenges for mask ventilation or intubation. 3. Age between 18 and 65 years. 4. Gender is not restricted. 5. ASA classification of I or II.

Exclusion criteria

1. Cardiovascular dysfunction or arterial aneurysms. 2. Mental or neurological disorders or concomitant arterial aneurysms. 3. Infection at the puncture site. 4. Allergy to local anesthetics. 5. Continuous use of antiplatelet or anticoagulant medications preoperatively. 6. Hoarseness or coughing while drinking water. 7. Bronchial asthma. 8. Participation in other clinical trials within the previous 3 months before enrollment 9.r current participation in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
quality of airway anesthesiaUpon intubationTThe primary outcome in this trial was quality of airway anesthesia assessed on a 5-point scale,Quality of airway anesthesia was graded as: 0=no coughing or gagging in response to intubation, 1=mild coughing and/or gagging that did not hinder intubation, 2=moderate coughing and/or gagging that interfered minimally with intubation, 3=severe coughing and/or gagging that made intubation difficult and 4=very severe coughing and/or gagging that required additional local anesthetic and/or change in technique.The lower grade means a better quality of airway anesthesia.

Secondary

MeasureTime frameDescription
Mean Arterial Pressure (MAP)T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubationStable blood pressure indicates a good neural blockade effect.
Heart Rate (HR)T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubationThe smaller the heart rate fluctuations, the better the neural blockade effect.
Ramsay Sedation ScoreT0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubationThe Ramsay Sedation Score is as follows: 6 points for unarousable, 5 points for slow response to stimulus, 4 points for asleep but easily aroused, 3 points for quiet and cooperative with orientation, 2 points for asleep, anxious, restless, and 1 point for asleep, agitated, and restless. Satisfactory sedation falls within 2-4 points, while oversedation is indicated by 5-6 points.
The number of patients with lowered pitchBefore intubationA lowered pitch indicates a good neural blockade effect.
The time of the block procedureFrom ultrasound probe positioning the target to completion of drug administrationThe neural blockade procedure time reflects the ease of the operation, with a shorter time indicating a simpler neural blockade procedure.
Record coughing in patients when the fiberoptic bronchoscope touches the glottisBefore intubationThe patient's coughing upon contact of the fiberoptic bronchoscope with the vocal cords before intubation reflects the effectiveness of neural blockade. A lower degree of coughing indicates a better neural blockade effect. 1 point for no response, 2 points for mild cough, 3 points for severe cough.
The tolerance of the tubeAfter successful intubationThe tolerance of the tube reflects the patient's tolerance to awake tracheal intubation. A higher level of tolerance indicates a better neural blockade effect. 3 points for severe resistance requiring immediate general anesthesia, 2 points for restlessness and mild resistance, 1 point for cooperation.
Adverse reactions such as coughing and nausea/ vomiting..During intubationThe lower the incidence of coughing, nausea, and vomiting, the better the neural blockade effect.
Occurrences of sore throat and lowered pitchPost-extubation,24 hours after surgeryPharyngeal pain and decreased vocal tone are used to assess postoperative complications of neural blockade.

Countries

China

Contacts

STUDY_CHAIRTao Shan

Nanjing First Hospital, Nanjing Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026